Penn researchers have developed a smarter AI method for solving notoriously difficult inverse equations, which help ...
A phase 1/2, first-in-human, open-label, dose-escalation study of TAK-280, an investigational B7-H3 x CD3ε conditional bispecific redirected activation (COBRA) T-cell engager, in adult patients with ...
Success is less about memorizing formulas and more about understanding process behavior, valves, operators and controller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results